American Journal of Epidemiology Vol. 152, No. 10 : 912
Copyright © 2000 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
An Author Responds to Meigs' Invited Commentary
From the Departments of Pathology and Biochemistry, College of Medicine, University of Vermont, Burlington, VT.
Abbreviations:
PAI-1, plasminogen activator inhibitor-1; PAP, plasmin-
2-antiplasmin
| INTRODUCTION |
|---|
In his commentary (1
First, the final position of plasminogen
| NOTES |
|---|
| REFERENCES |
|---|
Related articles in Am. J. Epidemiol.:
- Clustering of Procoagulation, Inflammation, and Fibrinolysis Variables with Metabolic Factors in Insulin Resistance Syndrome
- Pamela A. Sakkinen, Patricia Wahl, Mary Cushman, Michael R. Lewis, and Russell P. Tracy
Am. J. Epidemiol. 2000 152: 897-907.[Abstract] [FREE Full Text] - Invited Commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A Syndrome At All? Factor Analysis Reveals Patterns in the Fabric of Correlated Metabolic Risk Factors
- James B. Meigs
Am. J. Epidemiol. 2000 152: 908-911.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
H.-M. Lakka, D. E. Laaksonen, T. A. Lakka, L. K. Niskanen, E. Kumpusalo, J. Tuomilehto, and J. T. Salonen The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men JAMA, December 4, 2002; 288(21): 2709 - 2716. [Abstract] [Full Text] [PDF] |
||||
